Rigaku announces narcotics interdiction partnership program to help reduce deaths by overdose

Rigaku will partner with overdose prevention centers to fight the opioid epidemic

10 May 2022
Dora Wells
Clinical Content Editor

Industry news

In conjunction with the U.S. Drug Enforcement Agency (DEA)’s declaration of National Fentanyl Awareness Day, Rigaku Analytical Devices, a U.S.-based pioneer of handheld 1064 nm-Raman based spectrometers, has announced its new Human Infrastructure Health & Awareness (HIHA) Technology Narcotics Identification Partnership Program. This HIHA Program was developed to assist government health and social administration departments, and law enforcement agencies, in their efforts to reduce the increasing rates of unintentional drug overdoses and fatalities, related to opioid addiction and fentanyl poisoning.

As many communities consider the decriminalization of illicit drugs, and thus an increase in drug use, harm reduction programs that include overdose prevention centers (OPCs) are being funded as a means to help prevent fatal overdoses. OPCs provide a place for users to consume drugs using sterile equipment with access to health care professionals who administer first aid if needed, monitor for overdose, and provide referrals to drug treatment.

The goal of the Rigaku HIHA Program is to provide analytical technology to OPCs in order to screen the drug supplies being brought into the facility for hazardous chemicals, such as fentanyl, as well as provide an identification for the substance.

The Rigaku portfolio of 1064 nm-Raman based analyzers provide non-destructive analysis of unknown substances through packaging in less than one minute with the press of a button. The Rigaku ResQ CQL handheld analyzer contains a library with the latest illicit drugs, cutting agents, precursors, and hazardous chemicals - such as the various fentanyl compounds, as well as the ability to detect non-visible amounts with its use of QuickDetect Mode.

Designed for use in high stress environments, the Rigaku ResQ CQL uses a tactile platform, with smartphone-inspired software that can be operated via touchscreen or buttons. With thousands of analyzers in use around the world by the military, border protection, law enforcement, as well as first responders – the Rigaku portfolio of handheld Raman analyzers have the ability to identify dirty or mixed substances, even through packaging.

“It’s time for a new, humanitarian, and progressive approach to saving lives from preventable drug overdoses ,” said Michael Brown, Global Business Development Manager for Narcotics Interdiction Programs at Rigaku Analytical Devices. “Rigaku’s analyzers have the ability to provide frontline health responders with the ability to prevent a drug overdose before it happens.”

Rigaku’s HIHA Partnership Program provides a ResQ CQL with QuickDetect analyzer for an evaluation period, as well as training.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

Toxicology / Drugs of Abuse TestingToxicology and Drugs of Abuse Testing is the investigation into toxic and illegal substances found at the scene of a crime or from a suspect and / or victim associated with a scene of a crime. Analyzers, immunoassays and drugs of abuse test kits and presumptive test kits are an essential aspect of toxicology investigation.Drugs of AbuseA drug of abuse is a drug that has been taken for non-medical purposes. Such drugs can have mind-altering effects, with some causing dependence and addiction.Drug TestingIt is essential to test the efficacy and toxicity of drugs at every stage of their development to ensure that a pharmaceutical product is fit for purpose and safe for use before reaching the stage of mass production and distribution.Compound ScreeningCompound screening is a method used to discover specific compounds that could be promising candidates for pharmaceutical use. This potential is identified when compounds interact with the target protein during screening and could therefore be carried forward in the drug development process.Opiates
Rigaku announces narcotics interdiction partnership program to help reduce deaths by overdose